Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

145.01 -1.81 (-1.23%)
Streaming Delayed Price Updated: 2:35 PM EDT, Jun 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
Safe Havens: 3 Fixed-Income Securities for a Balanced Portfolio in 2024
If you are looking for safe havens to turn to in 2024 then you should consider adding these investments to your portfolio. 
Via InvestorPlace
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations. 
Via Benzinga
Why Is Blood Purification Focused CytoSorbents Trading Lower Today?
CytoSorbents Corporation (NASDAQ: CTSO) released an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board for the... 
Via Benzinga
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes... 
Via Benzinga
How Is The Market Feeling About Johnson & Johnson?
Via Benzinga
Check Out What Whales Are Doing With JNJ
Via Benzinga
Why NYSE:JNJ qualifies as a good dividend investing stock.
Uncovering Dividend Opportunities with JOHNSON & JOHNSON (NYSE:JNJ). 
Via Chartmill
Warren Buffett Dumped These 2 Top Dividend Stocks. Should You Follow His Lead?
Buffett didn't say why he closed positions in two stocks with underlying businesses that are doing well at the moment. 
Via The Motley Fool
Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness
Discover these innovative healthcare stocks, backed by the U.S.'s $4.3 trillion health investment, offering stability and high returns. 
Via InvestorPlace
Is It Time to Buy the Dow Jones' 3 Worst Performing Stocks This Year?
These stocks have significantly underperformed the market. But are they really "cheap"? 
Via The Motley Fool
Topics Stocks
Exposures US Equities
3 No-Brainer Stocks to Buy With $200 Right Now
A reasonably modest amount of money can go a long way when it's invested in innovation-driven businesses. 
Via The Motley Fool
Nasdaq Leads Over NYSE in IPO Listings, Drawing Major Tech and Global Firms in 2023
Nasdaq, Inc. (NASDAQ: NDAQ) is reportedly poised to outpace the New York Stock Exchange in  
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
7 Rock-Solid Dividend Stocks to Trust in Difficult Times
With uncertainty still clouding the economic picture for 2024, investors should consider these solid dividend stocks to buy. 
Via InvestorPlace
3 Worst Performing Dow Jones Stocks In 2023
After a challenging and volatile year, the Dow Jones Industrial Average (DJIA) will probably finish 2023 with a positive return. The index has climbed about 13%, and much of the return has occurred in... 
Via Talk Markets
Topics Stocks
Exposures US Equities
2 Top Dividend Stocks You Can Buy and Hold Forever
These companies pay very durable dividends. 
Via The Motley Fool
What To Do With High-Flying Tech At The Start Of 2024?
Here, I will do two things. First, I will look at the macro backdrop at the start of 2024, and secondly I will run through the portfolio, how it is doing, and what changes I have made, or intend to... 
Via Talk Markets
5 Top Stocks to Buy With Your End-of-the-Year Bonus
Your bonus could become the gift that keeps on giving. 
Via The Motley Fool
Build Your Future Portfolio: 3 Generous Dividend Stocks
Enjoy passive income and capital appreciation in 2024 with these three dividend stocks to buy before the end of this year. 
Via InvestorPlace
Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?
MeiraGTx Holdings plc (NASDAQ: MGTX) on Thursday announced an asset purchase agreement with Janssen Pharmaceuticals Inc, a Johnson & Johnson (NYSE: JNJ) compan 
Via Benzinga
7 Stocks That Might Win on Election Year Uncertainty
Rancorous politics can still surprisingly yield shareholder profits. 
Via InvestorPlace
Got $1,000? 5 of the Safest Stocks to Buy for 2024
Regardless of what's thrown Wall Street's way in the new year, these tried-and-true companies can deliver for their shareholders. 
Via The Motley Fool
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n 
Via Benzinga
Exposures COVID-19
Judge Bars Testimony Linking Kenvue's Pain Killer Tylenol to Autism in Pregnancy
U.S. 
Via Benzinga
Forever Favorites: 7 Dividend Stocks to Buy and Never Sell
There's no better investment strategy than choosing dividend stocks to buy and hold as the provide income and capital appreciation 
Via InvestorPlace
7 New Year’s Stocks to Buy to Get 2024 Off to a Bright Start
With one year down and another soon coming up, investors should take the time to consider these stocks to buy for 2024. 
Via InvestorPlace
3 Healthcare Stocks That Could Help Make You a Millionaire
These stocks each have reached an important turning point that could signal growth ahead. 
Via The Motley Fool
3 of the Most Attractive Dividend Stocks in the Pharma Space
Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere. 
Via InvestorPlace
The Dogs of the Dow May Pay Big Dividends in 2024
The dogs of the Dow could be great buys in 2024 for investors looking to take a chance on some underdogs that pay dividends too. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
The 7 Most Undervalued Dividend Stocks to Buy in December
Enjoy passive income throughout 2024 and watch your investment grow with these dividend stocks to buy this month. 
Via InvestorPlace
AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial
AC Immune SA's (NASDAQ: ACIU) development partner has programmed the launch of a Phase 2b clinical study to evaluate ACI-35.030 (JNJ-64042056) in patients with... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.